Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients After Percutaneous Coronary Intervention: A Hospital-Based Survey
Overview
Biotechnology
General Medicine
Authors
Affiliations
Background: To evaluate whether a reduced left ventricular ejection fraction (LVEF) is a risk factor in patients after percutaneous coronary intervention (PCI).
Methods: A retrospective cohort study from February 2013 to January 2017 was performed, and 1600 patients were included (136 patients with EF <50% and 1464 patients with EF ≥50%); all patients underwent PCI. Revascularization, in-hospital mortality, and in-hospital myocardial infarction (MI) during hospitalization were evaluated.
Results: The mean age of patients with EF <50% was 62.18 ± 10.31 years, while the mean age of patients with EF ≥50% was 60.06 ± 10.89 years (P=0.029). In-hospital mortality of patients with EF ≥50% was significantly lower than that of patients with EF <50% (0.12% vs. 3.68%, P<0.001), while no difference was observed in revascularization and in-hospital MI between the two groups (2.39% vs. 2.20%, P=0.892; 0.415% vs. 1.47%, P=0.093, respectively). In the univariate analysis, no significant difference was found in revascularization and in-hospital MI between the two groups (OR: 1.50, 95% CI: 0.95 to 2.38; OR: 0.28, 95% CI: 0.06 to 1.38, respectively) except for in-hospital mortality (OR: 1.12, 95% CI: 1.05 to 1.27). In multivariate analyses, in-hospital mortality of patients with EF ≥50% was still significantly lower than of patients with EF <50% (OR: 1.15, 95% CI: 1.08 to 1.33). There were no differences in revascularization and in-hospital MI between the two groups (OR: 0.85, 95% CI: 0.44 to 1.63; OR: 0.04, 95% CI: 0.00 to 1.84, respectively).
Conclusions: Reduced LVEF is a risk factor for in-hospital mortality in patients after PCI.
Maier A, Gissler M, Jackel M, Oettinger V, Bacmeister L, Heidenreich A Clin Res Cardiol. 2024; .
PMID: 39259363 DOI: 10.1007/s00392-024-02538-8.
Yang M, Guo F, Yang Y, Jing Z, Sun K Rev Cardiovasc Med. 2024; 24(3):80.
PMID: 39077497 PMC: 11264021. DOI: 10.31083/j.rcm2403080.
Kacmaz M, Schlettert C, Kreimer F, Abumayyaleh M, Akin I, Mugge A J Clin Med. 2024; 13(10).
PMID: 38792370 PMC: 11121874. DOI: 10.3390/jcm13102826.
Optimized patient selection in high-risk protected percutaneous coronary intervention.
Leick J, Werner N, Mangner N, Panoulas V, Aurigemma C Eur Heart J Suppl. 2022; 24(Suppl J):J4-J10.
PMID: 36518889 PMC: 9730792. DOI: 10.1093/eurheartjsupp/suac060.
Tayal R, Kalra S, Seth A, Chandra P, Sohal S, Punamiya K AsiaIntervention. 2022; 8(2):75-85.
PMID: 36483283 PMC: 9706744. DOI: 10.4244/AIJ-D-22-00021.